Regencell Bioscience Holdings Limited (RGC) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Regencell Bioscience Holdings Limited (RGC).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $29.42

Daily Change: -$1.07 / 3.64%

Range: $27.25 - $30.09

Market Cap: $382,839,520

Volume: 11,763

Performance Metrics

1 Week: 7.96%

1 Month: -30.78%

3 Months: 516.8%

6 Months: 488.4%

1 Year: 740.6%

YTD: 495.6%

Company Details

Employees: 12

Sector: Health technology

Industry: Pharmaceuticals: major

Country: Hong Kong

Details

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Selected stocks

NAYA Biosciences, Inc. (NAYA)

Pharming Group N.V. (PHAR)

Phathom Pharmaceuticals, Inc. (PHAT)